News List

Bayer’s new symptomatic chronic heart failure treatment Verquvo™ (vericiguat) approved in EU
2021-07-27

Berlin, Germany, July 21, 2021– The European Commission has granted marketing authorization in the E

USFDA approves KIT inhibitor Ayvakit (Avatinib)
2021-06-25

CStone's partner Blueprint Medicines recently announced that the U.S. Food and Drug Administrati

Xofluza was approved in China
2021-05-13

On April 29, 2021, Roche China announced that its innovative influenza drug Xofluza® (Mabaloxavir) h

Tagrisso approved in China in early lung cancer
2021-04-16

AstraZeneca'sTagrisso(osimertinib) has been approved in China for the adjuvant treatment of pati

Gilead’s Investigational Lenacapavir Demonstrates Sustained Long-Acting Efficacy Through Week 26 in Data Presented at CROI
2021-03-15

Gilead Sciences, Inc. (Nasdaq: GILD) today presented additional results from the Phase 2/3 CAPELLA t

BeiGene Announces EMA Acceptance of its Marketing Authorization Application for BRUKINSA® (Zanubrutinib) for the Treatment of Patients with WM
2021-02-25

On June 18, 2020, BeiGene, Ltd. (“BeiGene” or the “Company”), a commercial-stage biotechnology compa

VISEN Pharmaceutical's TransCon C-type natriuretic peptide Phase II clinical trial application approved in China
2021-02-09

January 7, VISEN Pharmaceuticals announced that it had submitted TransCon CNP (TransCon C-type natri

Progress in the development of new and efficient diabetes treatment drugs
2021-01-20

Recently, Wang Junfeng's research team from Hefei Institute of Material Science, Chinese Academy

FDA Grants Priority Review to Merck’s Supplemental Biologics License Application for KEYTRUDA
2020-12-22

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the U.S.